Worldwide, it’s the leading killer of women aged 35 to 54, with the Philippines ranking the 9th highest in incidence rate. In Asia, the country ranked 1st place. The awakening to confront the grim statistics of breast cancer incidence through early detection, advanced treatment solutions, and comprehensive therapies is ringing louder and clearer - and the country has found a formidable ally in Siemens.

The University of Perpetual Help with branches in Las Piñas and Laguna pioneered the initiative by building the country’s first fully digital facility ensemble, dedicated to breast imaging. Its latest addition is the Siemens Mammomat Inspiration, an integrated mammography platform for screening, diagnostics and biopsy.  With superior imaging quality, time-saving work flow functions, and patient-friendly features, it did not take much time for Mammomat Inspiration to make a medical breakthrough in breast care.

Equipped with Tungsten® technology, the Mammomat Inspiration comes with a pain- free, risk-free assurance towards patients through a significantly reduced radiation exposure. While the Opcomp® feature enables controlled compression for breasts, giving maximum and personalized comfort to every patient going through the test. 

Working in concert with the Mammomat Inspiration, the Siemens Acuson S2000 ABVS automated breast volume scanning ultrasound system was made part of the pact.  It peeks deeper into dense breast tissues with next-generation acoustic technologies. With an optimized high frequency imaging ability, it is able to give never-before-seen details during examinations. Topped off with a Picture Archiving Communications System (PACS) and a comprehensive data management system, clinical operators can achieve unparalleled diagnostics accuracy with efficient clinical workflow in the entire stream of breast care diagnostics.

Now major hospitals around the country are coming on full force in combating breast cancer in the Philippines with the same strategy – partnering a trusted company with continuous Answers for Life.